The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01180907 |
Recruitment Status :
Completed
First Posted : August 12, 2010
Last Update Posted : July 31, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Cancer Inflammation |
Study Type : | Observational |
Actual Enrollment : | 10 participants |
Official Title: | The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases: A Pilot Study |
Study Start Date : | November 2007 |
Actual Primary Completion Date : | November 2011 |
Group/Cohort |
---|
patients with cancer |
patients with autoimmune diseases |
healthy subjects |

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- > 18 years of age
- women of childbearing potential will undergo a pregnancy test free of charge
- patients with cancer or autoimmune diseases or healthy subjects

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01180907
United States, California | |
UCLA | |
Los Angeles, California, United States, 90095 |
Principal Investigator: | Christiaan Schiepers, M.D. Ph.D | University of California, Los Angeles |
Responsible Party: | Jonsson Comprehensive Cancer Center |
ClinicalTrials.gov Identifier: | NCT01180907 |
Other Study ID Numbers: |
07-07-071 DE-PS02-08ER-08-01 ( Other Grant/Funding Number: Department of Energy ) CIRMNo. RT1-01126-1 ( Other Grant/Funding Number: California Institute for Regenerative Medicine ) 10-000269 ( Other Identifier: UCLA Medical IRB#2 ) |
First Posted: | August 12, 2010 Key Record Dates |
Last Update Posted: | July 31, 2012 |
Last Verified: | July 2012 |
18F-FAC imaging cancer inflammation PET |
Inflammation Pathologic Processes |